feed,title,long_url,short_url
Investing,Johnson & Johnson prices consumer spinoff Kenvue at $20-$23 a share in IPO,https://www.investing.com/news/stock-market-news/johnson--johnson-prices-consumer-spinoff-kenvue-at-2023-a-share-in-ipo-3063218,https://da.gd/4the
Investing,"Ideaya Biosciences upgraded to Buy, shares jump on positive Interim Phase 2 data for Darovasertib and Crizotinib combination",https://www.investing.com/news/stock-market-news/ideaya-biosciences-upgraded-to-buy-shares-jump-on-positive-interim-phase-2-data-for-darovasertib-and-crizotinib-combination-432SI-3063206,https://da.gd/eRewj
Investing,J&J aims for up to $43 billion valuation for consumer health unit Kenvue,https://www.investing.com/news/economy/jj-aims-for-up-to-43-billion-valuation-for-consumer-health-unit-kenvue-3063214,https://da.gd/yXM7M
